The Artificial Organs Market is being driven by Increasing prevalence of chronic disorders
The Artificial Organs Market is expected to grow at a CAGR of 9.49% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 14854.5 million. In the medical field, total artificial hearts (TAH) have emerged as a viable solution for patients with end-stage biventricular heart failure, who are awaiting orthotopic heart transplantation. Due to the increasing incidence of cardiovascular diseases, the number of patients requiring heart transplants exceeds the availability of donor hearts. To bridge this gap, TAHs have been approved for use as an intermediate to heart transplantation on a global scale. One notable vendor, SynCardia, offers a pneumatically driven TAH with a pulsatile system, capable of handling flows greater than 9 L/min. This TAH is designed for use as a bridge to transplantation (BTT) for patients at imminent risk of death from non-reversible, bi-ventricular failure.
Get more information on Artificial Organs Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
175 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.49% |
Market growth 2024-2028 |
USD 14854.5 million |
Market structure |
fragmentation |
YoY growth 2023-2024(%) |
8.79 |
Key countries |
US, Germany, UK, France, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Artificial organs have revolutionized the medical field, providing solutions for individuals suffering from nutrient and oxygen deficiencies due to organ failures or transplant surgeries. These organs, made from materials like steel, plastics, and silicon, offer temporary and permanent solutions for patients with renal replacement needs, such as those suffering from end-stage kidney disease or kidney failure. Vascularization is a critical aspect of artificial organs, ensuring the proper flow of nutrients and oxygen to the body. Advanced technologies like artificial intelligence are being used to improve the vascularization process and reduce organ rejection. Transplant surgeries for organs like the kidney, liver, and pancreas are common procedures that utilize both donated and artificial organs. However, organ donors remain scarce, leading to a growing demand for temporary and permanent artificial organs. Apheresis therapy is another application of artificial organs, used to treat respiratory diseases and heart diseases. Artificial organs like the artificial liver, artificial pancreas, and artificial kidney have become essential tools in medical care. Dialysis, a common treatment for kidney failure, relies on artificial kidneys to filter waste from the blood. The future of artificial organs holds great promise, with ongoing research and development in this field. Organ failures can occur due to various reasons, including road accidents and organ rejection. Live donor programs offer a solution for some patients, but artificial organs provide a viable alternative for those who do not have access to donors or who require long-term support. In conclusion, artificial organs play a crucial role in providing nutrients and oxygen to the body when natural organs fail. With advancements in technology and materials, these organs offer hope for individuals suffering from various organ failures and diseases.
The global healthcare supplies market encompasses the sector dedicated to research and development (R&D) of a diverse range of medical consumables, including diagnostic and therapeutic tools. According to Technavio, the market size is determined by the consolidated revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, and gowns. Key growth drivers for this market include the increasing elderly population, with projections indicating that by 2050, nearly one-quarter of the US population and by 2030 in Europe, will be over 60 years old. This demographic shift is expected to significantly increase demand for healthcare supplies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted